EIF2AK2 antibody (AA 11-42)
Quick Overview for EIF2AK2 antibody (AA 11-42) (ABIN3030884)
Target
See all EIF2AK2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 11-42
-
Purpose
- PKR Antibody
-
Purification
- Purified
-
Immunogen
- A portion of amino acids 11-42 from the human protein was used as the immunogen for this PKR antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the PKR antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the PKR antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- EIF2AK2 (Eukaryotic Translation Initiation Factor 2-alpha Kinase 2 (EIF2AK2))
-
Alternative Name
- PKR
-
Background
- Interferon-induced, double-stranded RNA-activated protein kinase (PRKR/PKR) is a serine-threonine kinase. Activation by dsRNAs leads to autophosphorylation of PKR and allows the kinase to phosphorylate its natural substrate, the alpha subunit of eukaryotic protein synthesis initiation factor-2 (EIF2-alpha), leading to the inhibition of protein synthesis. PRKR, which is involved in TLR signaling and mediates apoptosis in fibroblasts in response to viral infection and inflammatory cytokines, activates IKK and NFKB, thereby suppressing apoptosis. Apoptosis induced by live pathogenic gram-positive and gram-negative bacteria requirs both TLR4 and PKR, possibly representing a major mechanism for pathogenic bacteria that use specific virulence factors to avoid detection and destruction by the innate immune system.
-
UniProt
- P19525
-
Pathways
- DNA Damage Repair, ER-Nucleus Signaling, Hepatitis C
Target
-